Cancer Medicine Publishes Issue 1:3
The journal brings together articles on a range of oncology specialties, covering cancer biology, clinical cancer research and cancer prevention, with authors from across the globe.
Below are some top articles which Editor-in-Chief Prof. Qingyi Wei has highlighted from the issue. We hope that you enjoy this exciting new content.
Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis
Sheng Wu, Seema Singh, Michelle L. Varney, Scott Kindle and Rakesh K. Singh
Summary: CXCL-8 is a direct determinant of aggressive melanoma phenotypes, including tumor growth, metastasis, and angiogenesis, and targeting CXCL-8 produced by tumor cells and the supporting stroma is a direction for studying this pathway to develop future melanoma diagnostics and therapeutics.
Effectiveness of aromatase inhibitors and tamoxifen in reducing subsequent breast cancer
Reina Haque, Syed A. Ahmed, Alice Fisher, Chantal C. Avila, Jiaxiao Shi, Amy Guo, T. Craig Cheetham and Joanne E. Schottinger
Summary: Women who take aromatase inhibitors (AIs) alone or following tamoxifen treatment have subsequent breast cancer rates similar to women treated exclusively with tamoxifen even after accounting for adherence.
Urban–rural disparities in colorectal cancer screening: cross-sectional analysis of 1998–2005 data from the Centers for Disease Control’s Behavioral Risk Factor Surveillance Study
Allison M. Cole, J. Elizabeth Jackson and Mark Doescher
Summary: Colorectal cancer screening is effective, yet underused. Rural residents may face increased barriers to screening compared with urban residents. We describe significant urban–rural colorectal cancer screening disparities in the United States.
Cancer Medicine is a peer reviewed, interdisciplinary journal providing rapid publication of cutting-edge research from global biomedical researchers across the cancer sciences.